<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	>

<channel>
	<title>PR Hub &#187; Pleasanton</title>
	<atom:link href="http://pr.gaeatimes.com/t/pleasanton/feed/" rel="self" type="application/rss+xml" />
	<link>http://pr.gaeatimes.com</link>
	<description></description>
	<pubDate>Fri, 16 Dec 2011 05:00:00 +0000</pubDate>
	<generator>http://wordpress.org/?v=2.7.1</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>New Roche Screening Test for Abacavir Hypersensitivity Available in Europe</title>
		<link>http://pr.gaeatimes.com/new-roche-screening-test-for-abacavir-hypersensitivity-available-in-europe-54940/</link>
		<comments>http://pr.gaeatimes.com/new-roche-screening-test-for-abacavir-hypersensitivity-available-in-europe-54940/#comments</comments>
		<pubDate>Fri, 16 Dec 2011 05:00:00 +0000</pubDate>
		<dc:creator>Roche</dc:creator>
		
		<category><![CDATA[Business]]></category>

		<category><![CDATA[Clinical Trials / Medical Discoveries]]></category>

		<category><![CDATA[Health]]></category>

		<category><![CDATA[Health Care / Hospitals]]></category>

		<category><![CDATA[New Products / Services]]></category>

		<category><![CDATA[Pharmaceuticals]]></category>

		<category><![CDATA[california]]></category>

		<category><![CDATA[December 16]]></category>

		<category><![CDATA[Pleasanton]]></category>

		<category><![CDATA[Roche]]></category>

		<category><![CDATA[Western Europe]]></category>

		<guid isPermaLink="false">http://pr.gaeatimes.com/new-roche-screening-test-for-abacavir-hypersensitivity-available-in-europe-54940/</guid>
		<description><![CDATA[PLEASANTON, California, December 16, 2011  -

- The test confidently detects HLA-B*5701 to help decrease risk of abacavir hypersensitivity reaction
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that its HLA-B*5701 screening test[1] is now commercially available in Europe. HLA-B*5701 screening provides physicians with a means to avoid prescribing drugs to patients at high risk of .... Source &nbsp;: <a href="http://pr.gaeatimes.com/new-roche-screening-test-for-abacavir-hypersensitivity-available-in-europe-54940/" title="New Roche Screening Test for Abacavir Hypersensitivity Available in Europe">Gaea News Network</a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/new-roche-screening-test-for-abacavir-hypersensitivity-available-in-europe-54940/feed/</wfw:commentRss>
		</item>
		<item>
		<title>CooperVision Continues the Voluntary Recall of Avaira™ Toric Contact Lenses</title>
		<link>http://pr.gaeatimes.com/coopervision-continues-the-voluntary-recall-of-avaira%e2%84%a2-toric-contact-lenses-51783/</link>
		<comments>http://pr.gaeatimes.com/coopervision-continues-the-voluntary-recall-of-avaira%e2%84%a2-toric-contact-lenses-51783/#comments</comments>
		<pubDate>Wed, 12 Oct 2011 05:00:00 +0000</pubDate>
		<dc:creator>Coopervision Inc.</dc:creator>
		
		<category><![CDATA[Consumer Products]]></category>

		<category><![CDATA[Cosmetics and Personal Care]]></category>

		<category><![CDATA[Health]]></category>

		<category><![CDATA[Health Care / Hospitals]]></category>

		<category><![CDATA[Household / Consumer / Cosmetics]]></category>

		<category><![CDATA[Pharmaceuticals]]></category>

		<category><![CDATA[Product Recalls]]></category>

		<category><![CDATA[california]]></category>

		<category><![CDATA[Coopervision Inc.]]></category>

		<category><![CDATA[October 12]]></category>

		<category><![CDATA[Pleasanton]]></category>

		<guid isPermaLink="false">http://pr.gaeatimes.com/coopervision-continues-the-voluntary-recall-of-avaira%e2%84%a2-toric-contact-lenses-51783/</guid>
		<description><![CDATA[PLEASANTON, California, October 12, 2011  -


CooperVision, Inc. is continuing to work with the FDA, distributors, customers, eye care practitioners and lens wearers to complete the recall initiated on August 19, 2011 on certain lots of Avaira&#8482; Toric contact lenses.
&#8220;Our first priority is always the health and safety of all CooperVision lens wearers and as ... <a href="http://pr.gaeatimes.com/coopervision-continues-the-voluntary-recall-of-avaira%e2%84%a2-toric-contact-lenses-51783/">Read this article on Gaea Times at  : CooperVision Continues the Voluntary Recall of Avaira™ Toric Contact Lenses</a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/coopervision-continues-the-voluntary-recall-of-avaira%e2%84%a2-toric-contact-lenses-51783/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Companion Diagnostic Test That Identifies Patients With Melanoma Tumor Mutation Available in Europe</title>
		<link>http://pr.gaeatimes.com/companion-diagnostic-test-that-identifies-patients-with-melanoma-tumor-mutation-available-in-europe-49375/</link>
		<comments>http://pr.gaeatimes.com/companion-diagnostic-test-that-identifies-patients-with-melanoma-tumor-mutation-available-in-europe-49375/#comments</comments>
		<pubDate>Tue, 23 Aug 2011 05:00:00 +0000</pubDate>
		<dc:creator>Roche</dc:creator>
		
		<category><![CDATA[Biotechnology]]></category>

		<category><![CDATA[Business]]></category>

		<category><![CDATA[Health]]></category>

		<category><![CDATA[Health Care / Hospitals]]></category>

		<category><![CDATA[New Products / Services]]></category>

		<category><![CDATA[Pharmaceuticals]]></category>

		<category><![CDATA[August 23]]></category>

		<category><![CDATA[california]]></category>

		<category><![CDATA[Pleasanton]]></category>

		<category><![CDATA[Roche]]></category>

		<category><![CDATA[Switzerland]]></category>

		<guid isPermaLink="false">http://pr.gaeatimes.com/companion-diagnostic-test-that-identifies-patients-with-melanoma-tumor-mutation-available-in-europe-49375/</guid>
		<description><![CDATA[PLEASANTON, California, August 23, 2011  -


- cobas BRAF Mutation Test is used to identify patients with melanoma tumors that harbor a genetic mutation which can be treated with Zelboraf (vemurafenib)
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the cobas BRAF Mutation Test is now commercially available in Europe and in countries that recognize .... <a href="http://pr.gaeatimes.com/companion-diagnostic-test-that-identifies-patients-with-melanoma-tumor-mutation-available-in-europe-49375/">Source article &nbsp;: Companion Diagnostic Test That Identifies Patients With Melanoma Tumor Mutation Available in Europe</a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/companion-diagnostic-test-that-identifies-patients-with-melanoma-tumor-mutation-available-in-europe-49375/feed/</wfw:commentRss>
		</item>
		<item>
		<title>KRAS Diagnostic Test That Assists With Personalized Treatment of Colorectal Cancer Receives CE Mark</title>
		<link>http://pr.gaeatimes.com/kras-diagnostic-test-that-assists-with-personalized-treatment-of-colorectal-cancer-receives-ce-mark-48277/</link>
		<comments>http://pr.gaeatimes.com/kras-diagnostic-test-that-assists-with-personalized-treatment-of-colorectal-cancer-receives-ce-mark-48277/#comments</comments>
		<pubDate>Fri, 22 Jul 2011 05:00:00 +0000</pubDate>
		<dc:creator>Roche Molecular Systems Inc.</dc:creator>
		
		<category><![CDATA[Biotechnology]]></category>

		<category><![CDATA[Business]]></category>

		<category><![CDATA[Health]]></category>

		<category><![CDATA[Health Care / Hospitals]]></category>

		<category><![CDATA[New Products / Services]]></category>

		<category><![CDATA[Pharmaceuticals]]></category>

		<category><![CDATA[california]]></category>

		<category><![CDATA[July 22]]></category>

		<category><![CDATA[Pleasanton]]></category>

		<category><![CDATA[Roche Molecular Systems Inc.]]></category>

		<category><![CDATA[Switzerland]]></category>

		<guid isPermaLink="false">http://pr.gaeatimes.com/kras-diagnostic-test-that-assists-with-personalized-treatment-of-colorectal-cancer-receives-ce-mark-48277/</guid>
		<description><![CDATA[PLEASANTON, California, July 22, 2011  -


- cobas KRAS
Mutation Test identifies colorectal cancer patients not likely to
respond to anti-EGFR antibody therapies.
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the
cobas KRAS Mutation Test is now commercially available in Europe
for use in colorectal cancer.
The cobas KRAS Mutation Test identifies mutations in the KRAS
gene of colorectal cancer ... <a href="http://pr.gaeatimes.com/kras-diagnostic-test-that-assists-with-personalized-treatment-of-colorectal-cancer-receives-ce-mark-48277/">Read more : KRAS Diagnostic Test That Assists With Personalized Treatment of Colorectal Cancer Receives CE Mark</a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/kras-diagnostic-test-that-assists-with-personalized-treatment-of-colorectal-cancer-receives-ce-mark-48277/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Blood Screening Test That Offers Immediate Viral Discrimination for Three Major Viruses Receives CE Mark</title>
		<link>http://pr.gaeatimes.com/blood-screening-test-that-offers-immediate-viral-discrimination-for-three-major-viruses-receives-ce-mark-45537/</link>
		<comments>http://pr.gaeatimes.com/blood-screening-test-that-offers-immediate-viral-discrimination-for-three-major-viruses-receives-ce-mark-45537/#comments</comments>
		<pubDate>Mon, 23 May 2011 05:00:00 +0000</pubDate>
		<dc:creator>Roche</dc:creator>
		
		<category><![CDATA[Business]]></category>

		<category><![CDATA[Health]]></category>

		<category><![CDATA[Health Care / Hospitals]]></category>

		<category><![CDATA[Medical Equipment]]></category>

		<category><![CDATA[New Products / Services]]></category>

		<category><![CDATA[Pharmaceuticals]]></category>

		<category><![CDATA[california]]></category>

		<category><![CDATA[May 23]]></category>

		<category><![CDATA[Pleasanton]]></category>

		<category><![CDATA[Roche]]></category>

		<guid isPermaLink="false">http://pr.gaeatimes.com/blood-screening-test-that-offers-immediate-viral-discrimination-for-three-major-viruses-receives-ce-mark-45537/</guid>
		<description><![CDATA[PLEASANTON, California, May 23, 2011  -

    - cobas(R) TaqScreen MPX Test, v2.0(1) provides real-time results for
HIV, HCV and HBV
    Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the cobas(R)
TaqScreen MPX Test, version 2.0 for use on the cobas s 201 system is now
commercially available in Europe.
  ... <a href="http://pr.gaeatimes.com/blood-screening-test-that-offers-immediate-viral-discrimination-for-three-major-viruses-receives-ce-mark-45537/" title="Blood Screening Test That Offers Immediate Viral Discrimination for Three Major Viruses Receives CE Mark">Read more &raquo;&raquo;</a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/blood-screening-test-that-offers-immediate-viral-discrimination-for-three-major-viruses-receives-ce-mark-45537/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Roche Expands Use of Novel HIV Test</title>
		<link>http://pr.gaeatimes.com/roche-expands-use-of-novel-hiv-test-45458/</link>
		<comments>http://pr.gaeatimes.com/roche-expands-use-of-novel-hiv-test-45458/#comments</comments>
		<pubDate>Thu, 19 May 2011 05:00:00 +0000</pubDate>
		<dc:creator>Roche</dc:creator>
		
		<category><![CDATA[Biotechnology]]></category>

		<category><![CDATA[Health]]></category>

		<category><![CDATA[Health Care / Hospitals]]></category>

		<category><![CDATA[Pharmaceuticals]]></category>

		<category><![CDATA[california]]></category>

		<category><![CDATA[May 19]]></category>

		<category><![CDATA[Pleasanton]]></category>

		<category><![CDATA[Roche]]></category>

		<category><![CDATA[Switzerland]]></category>

		<guid isPermaLink="false">http://pr.gaeatimes.com/roche-expands-use-of-novel-hiv-test-45458/</guid>
		<description><![CDATA[Test with enhanced reliability for monitoring HIV patients now CE marked
PLEASANTON, California, May 19, 2011  - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that it has received
CE mark for the expanded use of its novel HIV test(1). This allows the test
to be used in smaller laboratory settings. In the face of the rapidly  [..] <a href="http://pr.gaeatimes.com/roche-expands-use-of-novel-hiv-test-45458/">Read the original article: here</a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/roche-expands-use-of-novel-hiv-test-45458/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Roche&apos;s Test for Cytomegalovirus Is Approved in Europe</title>
		<link>http://pr.gaeatimes.com/roches-test-for-cytomegalovirus-is-approved-in-europe-43455/</link>
		<comments>http://pr.gaeatimes.com/roches-test-for-cytomegalovirus-is-approved-in-europe-43455/#comments</comments>
		<pubDate>Thu, 31 Mar 2011 05:00:00 +0000</pubDate>
		<dc:creator>Roche Molecular Systems</dc:creator>
		
		<category><![CDATA[Health]]></category>

		<category><![CDATA[Health Care / Hospitals]]></category>

		<category><![CDATA[Infectious Disease Control]]></category>

		<category><![CDATA[Pharmaceuticals]]></category>

		<category><![CDATA[california]]></category>

		<category><![CDATA[Europe]]></category>

		<category><![CDATA[March 31]]></category>

		<category><![CDATA[Pleasanton]]></category>

		<category><![CDATA[Roche Molecular Systems]]></category>

		<guid isPermaLink="false">http://pr.gaeatimes.com/roches-test-for-cytomegalovirus-is-approved-in-europe-43455/</guid>
		<description><![CDATA[Test measures viral load of potentially deadly virus for transplant patients

PLEASANTON, California, March 31, 2011  - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that its
Cytomegalovirus (CMV) test(1) is now commercially available in Europe. CMV
viral load testing helps physicians manage immunocompromised patients at risk
of CMV disease, including those who have undergone solid organ and ... <a href="http://pr.gaeatimes.com/roches-test-for-cytomegalovirus-is-approved-in-europe-43455/">Read this article on Gaea Times at  : Roche&apos;s Test for Cytomegalovirus Is Approved in Europe</a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/roches-test-for-cytomegalovirus-is-approved-in-europe-43455/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Veeva Systems Launches First Integrated Pharma CRM and CLM Solution Designed for the Apple iPad</title>
		<link>http://pr.gaeatimes.com/veeva-systems-launches-first-integrated-pharma-crm-and-clm-solution-designed-for-the-apple-ipad-39877/</link>
		<comments>http://pr.gaeatimes.com/veeva-systems-launches-first-integrated-pharma-crm-and-clm-solution-designed-for-the-apple-ipad-39877/#comments</comments>
		<pubDate>Tue, 11 Jan 2011 05:00:00 +0000</pubDate>
		<dc:creator>Veeva Systems</dc:creator>
		
		<category><![CDATA[Business]]></category>

		<category><![CDATA[Computer / Electronics]]></category>

		<category><![CDATA[Health]]></category>

		<category><![CDATA[Medical Equipment]]></category>

		<category><![CDATA[New Products / Services]]></category>

		<category><![CDATA[Pharmaceuticals]]></category>

		<category><![CDATA[Technology]]></category>

		<category><![CDATA[california]]></category>

		<category><![CDATA[January 11]]></category>

		<category><![CDATA[Pleasanton]]></category>

		<category><![CDATA[Veeva Systems]]></category>

		<guid isPermaLink="false">http://pr.gaeatimes.com/veeva-systems-launches-first-integrated-pharma-crm-and-clm-solution-designed-for-the-apple-ipad-39877/</guid>
		<description><![CDATA[New Veeva iRep Application Satisfies the Pharmaceutical Industry&apos;s Appetite for the Fastest Growing Computing Device in History

PLEASANTON, California, January 11, 2011  - Today Veeva Systems unveiled Veeva iRep, the pharmaceutical industry&#39;s
first complete customer relationship management (CRM) and closed loop
marketing (CLM) solution built exclusively for the iPad. The new solution
leverages the best of the iPad ... Read more <a href="http://pr.gaeatimes.com/veeva-systems-launches-first-integrated-pharma-crm-and-clm-solution-designed-for-the-apple-ipad-39877/" title="Veeva Systems Launches First Integrated Pharma CRM and CLM Solution Designed for the Apple iPad">>>></a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/veeva-systems-launches-first-integrated-pharma-crm-and-clm-solution-designed-for-the-apple-ipad-39877/feed/</wfw:commentRss>
		</item>
		<item>
		<title>QuantaLife, Inc. Closes $17.2M Series B Financing to Accelerate Application Development for Its Droplet Digital(TM) PCR Platform and Establish Commercial Operations by 2011</title>
		<link>http://pr.gaeatimes.com/quantalife-inc-closes-172m-series-b-financing-to-accelerate-application-development-for-its-droplet-digitaltm-pcr-platform-and-establish-commercial-operations-by-2011-39110/</link>
		<comments>http://pr.gaeatimes.com/quantalife-inc-closes-172m-series-b-financing-to-accelerate-application-development-for-its-droplet-digitaltm-pcr-platform-and-establish-commercial-operations-by-2011-39110/#comments</comments>
		<pubDate>Fri, 10 Dec 2010 05:00:00 +0000</pubDate>
		<dc:creator>Quantalife Inc.</dc:creator>
		
		<category><![CDATA[Biotechnology]]></category>

		<category><![CDATA[Health]]></category>

		<category><![CDATA[Health Care / Hospitals]]></category>

		<category><![CDATA[california]]></category>

		<category><![CDATA[December 10]]></category>

		<category><![CDATA[Pleasanton]]></category>

		<category><![CDATA[Quantalife Inc.]]></category>

		<category><![CDATA[Western Europe]]></category>

		<guid isPermaLink="false">http://pr.gaeatimes.com/quantalife-inc-closes-172m-series-b-financing-to-accelerate-application-development-for-its-droplet-digitaltm-pcr-platform-and-establish-commercial-operations-by-2011-39110/</guid>
		<description><![CDATA[PLEASANTON, California, December 10, 2010  - QuantaLife, Inc. announced today that it has closed a $17.2M Series B
financing. The majority of the proceeds will be used to establish commercial
operations for introduction of its first product, the Droplet Digital(TM) PCR
platform, into the life sciences research market early next year and
accelerate development of targeted diagnostic tests. ... <a href="http://pr.gaeatimes.com/quantalife-inc-closes-172m-series-b-financing-to-accelerate-application-development-for-its-droplet-digitaltm-pcr-platform-and-establish-commercial-operations-by-2011-39110/">Read more : QuantaLife, Inc. Closes $17.2M Series B Financing to Accelerate Application Development for Its Droplet Digital(TM) PCR Platform and Establish Commercial Operations by 2011</a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/quantalife-inc-closes-172m-series-b-financing-to-accelerate-application-development-for-its-droplet-digitaltm-pcr-platform-and-establish-commercial-operations-by-2011-39110/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Roche and German Cancer Research Center (DKFZ) Enter Research Agreement to Predict Cervical Cancer</title>
		<link>http://pr.gaeatimes.com/roche-and-german-cancer-research-center-dkfz-enter-research-agreement-to-predict-cervical-cancer-36317/</link>
		<comments>http://pr.gaeatimes.com/roche-and-german-cancer-research-center-dkfz-enter-research-agreement-to-predict-cervical-cancer-36317/#comments</comments>
		<pubDate>Mon, 11 Oct 2010 05:00:00 +0000</pubDate>
		<dc:creator>Roche Molecular Systems Inc.</dc:creator>
		
		<category><![CDATA[Biotechnology]]></category>

		<category><![CDATA[Business]]></category>

		<category><![CDATA[Health]]></category>

		<category><![CDATA[Health Care / Hospitals]]></category>

		<category><![CDATA[Pharmaceuticals]]></category>

		<category><![CDATA[Surveys / Polls / Research]]></category>

		<category><![CDATA[california]]></category>

		<category><![CDATA[October 11]]></category>

		<category><![CDATA[Pleasanton]]></category>

		<category><![CDATA[Roche Molecular Systems Inc.]]></category>

		<category><![CDATA[Scandinavia]]></category>

		<category><![CDATA[Western Europe]]></category>

		<guid isPermaLink="false">http://blog.taragana.com/pr/roche-and-german-cancer-research-center-dkfz-enter-research-agreement-to-predict-cervical-cancer-36317/</guid>
		<description><![CDATA[Collaboration is based on recent DKFZ discovery suggesting cervical cancer risk may be more precisely determined

PLEASANTON, California, October 11, 2010  - Roche Molecular Systems, Inc. (SIX: RO, ROG; OTCQX: RHHBY) and the German
Cancer Research Center (DKFZ) announced today that they have entered into a
research collaboration to enable more specific prediction of a woman&#39;s risk
for .... Original article &nbsp;: <a href="http://pr.gaeatimes.com/roche-and-german-cancer-research-center-dkfz-enter-research-agreement-to-predict-cervical-cancer-36317/">Roche and German Cancer Research Center (DKFZ) Enter Research Agreement to Predict Cervical Cancer</a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/roche-and-german-cancer-research-center-dkfz-enter-research-agreement-to-predict-cervical-cancer-36317/feed/</wfw:commentRss>
		</item>
		<item>
		<title>First Duplex Test for Parvovirus B19 and Hepatitis A Virus Increases Safety of Human Plasma and Plasma Products</title>
		<link>http://pr.gaeatimes.com/first-duplex-test-for-parvovirus-b19-and-hepatitis-a-virus-increases-safety-of-human-plasma-and-plasma-products-35896/</link>
		<comments>http://pr.gaeatimes.com/first-duplex-test-for-parvovirus-b19-and-hepatitis-a-virus-increases-safety-of-human-plasma-and-plasma-products-35896/#comments</comments>
		<pubDate>Mon, 04 Oct 2010 05:00:00 +0000</pubDate>
		<dc:creator>Roche</dc:creator>
		
		<category><![CDATA[Biotechnology]]></category>

		<category><![CDATA[Business]]></category>

		<category><![CDATA[Health]]></category>

		<category><![CDATA[Health Care / Hospitals]]></category>

		<category><![CDATA[Infectious Disease Control]]></category>

		<category><![CDATA[New Products / Services]]></category>

		<category><![CDATA[OTC / SmallCap]]></category>

		<category><![CDATA[Pharmaceuticals]]></category>

		<category><![CDATA[california]]></category>

		<category><![CDATA[October 4]]></category>

		<category><![CDATA[Pleasanton]]></category>

		<category><![CDATA[Roche]]></category>

		<category><![CDATA[Scandinavia]]></category>

		<category><![CDATA[Western Europe]]></category>

		<guid isPermaLink="false"></guid>
		<description><![CDATA[cobas(R) TaqScreen DPX Test offers real-time discrimination in a single assay(1)

PLEASANTON, California, October 4, 2010  - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the cobas(R)
TaqScreen DPX Test for use on the cobas s 201 system is now available with
the CE Mark. It is the first IVD test to offer complete coverage of ... <a href="http://pr.gaeatimes.com/first-duplex-test-for-parvovirus-b19-and-hepatitis-a-virus-increases-safety-of-human-plasma-and-plasma-products-35896/">Read this article on Gaea Times at  : First Duplex Test for Parvovirus B19 and Hepatitis A Virus Increases Safety of Human Plasma and Plasma Products</a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/first-duplex-test-for-parvovirus-b19-and-hepatitis-a-virus-increases-safety-of-human-plasma-and-plasma-products-35896/feed/</wfw:commentRss>
		</item>
		<item>
		<title>First Duplex Test for Parvovirus B19 and Hepatitis A Virus Increases Safety of Human Plasma and Plasma Products</title>
		<link>http://pr.gaeatimes.com/first-duplex-test-for-parvovirus-b19-and-hepatitis-a-virus-increases-safety-of-human-plasma-and-plasma-products-2-35898/</link>
		<comments>http://pr.gaeatimes.com/first-duplex-test-for-parvovirus-b19-and-hepatitis-a-virus-increases-safety-of-human-plasma-and-plasma-products-2-35898/#comments</comments>
		<pubDate>Mon, 04 Oct 2010 05:00:00 +0000</pubDate>
		<dc:creator>Roche</dc:creator>
		
		<category><![CDATA[Biotechnology]]></category>

		<category><![CDATA[Business]]></category>

		<category><![CDATA[Health]]></category>

		<category><![CDATA[Health Care / Hospitals]]></category>

		<category><![CDATA[Infectious Disease Control]]></category>

		<category><![CDATA[New Products / Services]]></category>

		<category><![CDATA[OTC / SmallCap]]></category>

		<category><![CDATA[Pharmaceuticals]]></category>

		<category><![CDATA[california]]></category>

		<category><![CDATA[October 4]]></category>

		<category><![CDATA[Pleasanton]]></category>

		<category><![CDATA[Roche]]></category>

		<category><![CDATA[Scandinavia]]></category>

		<category><![CDATA[Western Europe]]></category>

		<guid isPermaLink="false">http://blog.taragana.com/pr/first-duplex-test-for-parvovirus-b19-and-hepatitis-a-virus-increases-safety-of-human-plasma-and-plasma-products-2-35898/</guid>
		<description><![CDATA[cobas(R) TaqScreen DPX Test offers real-time discrimination in a single assay(1)

PLEASANTON, California, October 4, 2010  - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the cobas(R)
TaqScreen DPX Test for use on the cobas s 201 system is now available with
the CE Mark. It is the first IVD test to offer complete coverage of .... <a href="http://pr.gaeatimes.com/first-duplex-test-for-parvovirus-b19-and-hepatitis-a-virus-increases-safety-of-human-plasma-and-plasma-products-2-35898/">Read the original article &nbsp;: First Duplex Test for Parvovirus B19 and Hepatitis A Virus Increases Safety of Human Plasma and Plasma Products</a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/first-duplex-test-for-parvovirus-b19-and-hepatitis-a-virus-increases-safety-of-human-plasma-and-plasma-products-2-35898/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Roche Obtains Co-Exclusive License to Develop PCR Assays Detecting Mutations in the PI3K Oncogene</title>
		<link>http://pr.gaeatimes.com/roche-obtains-co-exclusive-license-to-develop-pcr-assays-detecting-mutations-in-the-pi3k-oncogene-23996/</link>
		<comments>http://pr.gaeatimes.com/roche-obtains-co-exclusive-license-to-develop-pcr-assays-detecting-mutations-in-the-pi3k-oncogene-23996/#comments</comments>
		<pubDate>Tue, 13 Jul 2010 05:00:00 +0000</pubDate>
		<dc:creator>Roche</dc:creator>
		
		<category><![CDATA[Biotechnology]]></category>

		<category><![CDATA[Clinical Trials / Medical Discoveries]]></category>

		<category><![CDATA[Health]]></category>

		<category><![CDATA[Health Care / Hospitals]]></category>

		<category><![CDATA[Pharmaceuticals]]></category>

		<category><![CDATA[california]]></category>

		<category><![CDATA[July 13]]></category>

		<category><![CDATA[Pleasanton]]></category>

		<category><![CDATA[Roche]]></category>

		<category><![CDATA[Scandinavia]]></category>

		<category><![CDATA[Western Europe]]></category>

		<guid isPermaLink="false">http://blog.taragana.com/pr/roche-obtains-co-exclusive-license-to-develop-pcr-assays-detecting-mutations-in-the-pi3k-oncogene-23996/</guid>
		<description><![CDATA[PLEASANTON, California, July 13, 2010  - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the company has
obtained a worldwide co-exclusive license for the biomarker PI3K
(phosphoinositide 3-kinase) from QIAGEN to develop real-time and endpoint PCR
diagnostic assays. Johns Hopkins University owns the patent for the PI3K
biomarker and has previously granted an exclusive license to QIAGEN&#39;s .... Source article &nbsp;: <a href="http://pr.gaeatimes.com/roche-obtains-co-exclusive-license-to-develop-pcr-assays-detecting-mutations-in-the-pi3k-oncogene-23996/">Roche Obtains Co-Exclusive License to Develop PCR Assays Detecting Mutations in the PI3K Oncogene</a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/roche-obtains-co-exclusive-license-to-develop-pcr-assays-detecting-mutations-in-the-pi3k-oncogene-23996/feed/</wfw:commentRss>
		</item>
		<item>
		<title>FDA Clears Roche&apos;s LightCycler(R) MRSA Advanced Test for Use in the U.S.</title>
		<link>http://pr.gaeatimes.com/fda-clears-roches-lightcyclerr-mrsa-advanced-test-for-use-in-the-us-23842/</link>
		<comments>http://pr.gaeatimes.com/fda-clears-roches-lightcyclerr-mrsa-advanced-test-for-use-in-the-us-23842/#comments</comments>
		<pubDate>Thu, 08 Jul 2010 05:00:00 +0000</pubDate>
		<dc:creator>Roche Molecular Systems Inc.</dc:creator>
		
		<category><![CDATA[FDA Approval]]></category>

		<category><![CDATA[Government and Policy]]></category>

		<category><![CDATA[Health]]></category>

		<category><![CDATA[Health Care / Hospitals]]></category>

		<category><![CDATA[Pharmaceuticals]]></category>

		<category><![CDATA[california]]></category>

		<category><![CDATA[July 8]]></category>

		<category><![CDATA[Pleasanton]]></category>

		<category><![CDATA[Roche Molecular Systems Inc.]]></category>

		<category><![CDATA[Scandinavia]]></category>

		<category><![CDATA[Western Europe]]></category>

		<guid isPermaLink="false">http://blog.taragana.com/pr/fda-clears-roches-lightcyclerr-mrsa-advanced-test-for-use-in-the-us-23842/</guid>
		<description><![CDATA[Easy-to-use molecular test offers faster results to help healthcare facilities control spread of methicillin-resistant Staphylococcus aureus (MRSA)

PLEASANTON, California, July 8, 2010  - Roche Molecular Systems, Inc. (SIX: RO, ROG; OTCQX: RHHBY) announced
today that the U.S. Food &#38; Drug Administration (FDA) cleared its new
LightCycler(R) MRSA Advanced Test for the detection of methicillin-resistant
Staphylococcus aureus (MRSA) for ... <a href="http://pr.gaeatimes.com/fda-clears-roches-lightcyclerr-mrsa-advanced-test-for-use-in-the-us-23842/" title="FDA Clears Roche&apos;s LightCycler(R) MRSA Advanced Test for Use in the U.S.">Read more >></a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/fda-clears-roches-lightcyclerr-mrsa-advanced-test-for-use-in-the-us-23842/feed/</wfw:commentRss>
		</item>
		<item>
		<title>FDA Approves New Roche Dual-PCR Target HIV-1 Test</title>
		<link>http://pr.gaeatimes.com/fda-approves-new-roche-dual-pcr-target-hiv-1-test-21455/</link>
		<comments>http://pr.gaeatimes.com/fda-approves-new-roche-dual-pcr-target-hiv-1-test-21455/#comments</comments>
		<pubDate>Fri, 04 Jun 2010 05:00:00 +0000</pubDate>
		<dc:creator>Roche Molecular Diagnostics</dc:creator>
		
		<category><![CDATA[FDA Approval]]></category>

		<category><![CDATA[Government and Policy]]></category>

		<category><![CDATA[Health]]></category>

		<category><![CDATA[Health Care / Hospitals]]></category>

		<category><![CDATA[Pharmaceuticals]]></category>

		<category><![CDATA[california]]></category>

		<category><![CDATA[June 4]]></category>

		<category><![CDATA[Pleasanton]]></category>

		<category><![CDATA[Roche Molecular Diagnostics]]></category>

		<category><![CDATA[Scandinavia]]></category>

		<category><![CDATA[Western Europe]]></category>

		<guid isPermaLink="false">http://blog.taragana.com/pr/fda-approves-new-roche-dual-pcr-target-hiv-1-test-21455/</guid>
		<description><![CDATA[First dual-PCR target viral load test approved for monitoring HIV patients receiving antiretroviral therapy

PLEASANTON, California, June 4, 2010  - Roche Molecular Diagnostics (SIX: RO, ROG: OTCQX: RHHBY) announced today
that the Food and Drug Administration (FDA) approved its new dual-PCR target
HIV-1 viral load test to quantify the amount of virus in a patient&#39;s blood.
The COBAS(R) .... Original source &nbsp;: <a href="http://pr.gaeatimes.com/fda-approves-new-roche-dual-pcr-target-hiv-1-test-21455/">FDA Approves New Roche Dual-PCR Target HIV-1 Test</a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/fda-approves-new-roche-dual-pcr-target-hiv-1-test-21455/feed/</wfw:commentRss>
		</item>
		<item>
		<title>CooperVision Adds Global Professional Relations Role; Richard Clompus Joins Company as Vice President</title>
		<link>http://pr.gaeatimes.com/coopervision-adds-global-professional-relations-role-richard-clompus-joins-company-as-vice-president-11813/</link>
		<comments>http://pr.gaeatimes.com/coopervision-adds-global-professional-relations-role-richard-clompus-joins-company-as-vice-president-11813/#comments</comments>
		<pubDate>Mon, 18 Jan 2010 05:00:00 +0000</pubDate>
		<dc:creator>Coopervision</dc:creator>
		
		<category><![CDATA[Business]]></category>

		<category><![CDATA[Health]]></category>

		<category><![CDATA[Health Care / Hospitals]]></category>

		<category><![CDATA[Medical Equipment]]></category>

		<category><![CDATA[Personnel Announcements]]></category>

		<category><![CDATA[Pharmaceuticals]]></category>

		<category><![CDATA[california]]></category>

		<category><![CDATA[Coopervision]]></category>

		<category><![CDATA[India]]></category>

		<category><![CDATA[Pleasanton]]></category>

		<category><![CDATA[Western Europe]]></category>

		<guid isPermaLink="false">http://blog.taragana.com/pr/coopervision-adds-global-professional-relations-role-richard-clompus-joins-company-as-vice-president-11813/</guid>
		<description><![CDATA[PLEASANTON, California, January 18  - CooperVision today announced that Richard Clompus, OD, FAAO, has joined
the company as vice president, global professional relations within the
Global Commercial Strategy team. Dr. Clompus will support clinical studies,
education, and professional affairs on a worldwide basis in order to further
establish CooperVision&#39;s position in the global contact lens industry.

   ... <a href="http://pr.gaeatimes.com/coopervision-adds-global-professional-relations-role-richard-clompus-joins-company-as-vice-president-11813/">Original article on  : CooperVision Adds Global Professional Relations Role; Richard Clompus Joins Company as Vice President</a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/coopervision-adds-global-professional-relations-role-richard-clompus-joins-company-as-vice-president-11813/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Roche Introduces New Automated Clinical Laboratory System for CE-Marked Testing of Human Papillomavirus, Chlamydia and N. gonorrhoeae</title>
		<link>http://pr.gaeatimes.com/roche-introduces-new-automated-clinical-laboratory-system-for-ce-marked-testing-of-human-papillomavirus-chlamydia-and-n-gonorrhoeae-10392/</link>
		<comments>http://pr.gaeatimes.com/roche-introduces-new-automated-clinical-laboratory-system-for-ce-marked-testing-of-human-papillomavirus-chlamydia-and-n-gonorrhoeae-10392/#comments</comments>
		<pubDate>Wed, 09 Dec 2009 05:00:00 +0000</pubDate>
		<dc:creator>Roche Molecular Systems Inc.</dc:creator>
		
		<category><![CDATA[Business]]></category>

		<category><![CDATA[Health]]></category>

		<category><![CDATA[Health Care / Hospitals]]></category>

		<category><![CDATA[New Products / Services]]></category>

		<category><![CDATA[Pharmaceuticals]]></category>

		<category><![CDATA[california]]></category>

		<category><![CDATA[Pleasanton]]></category>

		<category><![CDATA[Roche Molecular Systems Inc.]]></category>

		<category><![CDATA[Russia]]></category>

		<category><![CDATA[Western Europe]]></category>

		<guid isPermaLink="false">http://blog.taragana.com/pr/roche-introduces-new-automated-clinical-laboratory-system-for-ce-marked-testing-of-human-papillomavirus-chlamydia-and-n-gonorrhoeae-10392/</guid>
		<description><![CDATA[New cobas(R) 4800 System designed to increase laboratory efficiency and medical value

PLEASANTON, California, December 9  - Roche Molecular Systems, Inc. (SIX: RO, ROG; OTCQX: RHHBY) announced
today the launch of a new clinical laboratory system designed to increase
laboratory testing efficiency and to accommodate current and long-term
molecular diagnostic needs. The cobas(R) 4800 System combines CE-marked in
vitro ... <a href="http://pr.gaeatimes.com/roche-introduces-new-automated-clinical-laboratory-system-for-ce-marked-testing-of-human-papillomavirus-chlamydia-and-n-gonorrhoeae-10392/">Read more : Roche Introduces New Automated Clinical Laboratory System for CE-Marked Testing of Human Papillomavirus, Chlamydia and N. gonorrhoeae</a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/roche-introduces-new-automated-clinical-laboratory-system-for-ce-marked-testing-of-human-papillomavirus-chlamydia-and-n-gonorrhoeae-10392/feed/</wfw:commentRss>
		</item>
		<item>
		<title>FDA Approves Use of Roche Test to Screen Source Plasma for HIV, Hepatitis B Virus and Hepatitis C Virus</title>
		<link>http://pr.gaeatimes.com/fda-approves-use-of-roche-test-to-screen-source-plasma-for-hiv-hepatitis-b-virus-and-hepatitis-c-virus-9876/</link>
		<comments>http://pr.gaeatimes.com/fda-approves-use-of-roche-test-to-screen-source-plasma-for-hiv-hepatitis-b-virus-and-hepatitis-c-virus-9876/#comments</comments>
		<pubDate>Wed, 02 Dec 2009 05:00:00 +0000</pubDate>
		<dc:creator>Roche Molecular Systems Inc.</dc:creator>
		
		<category><![CDATA[FDA Approval]]></category>

		<category><![CDATA[Government and Policy]]></category>

		<category><![CDATA[Health]]></category>

		<category><![CDATA[Health Care / Hospitals]]></category>

		<category><![CDATA[Infectious Disease Control]]></category>

		<category><![CDATA[Medical Equipment]]></category>

		<category><![CDATA[Pharmaceuticals]]></category>

		<category><![CDATA[california]]></category>

		<category><![CDATA[Pleasanton]]></category>

		<category><![CDATA[Roche Molecular Systems Inc.]]></category>

		<category><![CDATA[Western Europe]]></category>

		<guid isPermaLink="false">http://blog.taragana.com/pr/fda-approves-use-of-roche-test-to-screen-source-plasma-for-hiv-hepatitis-b-virus-and-hepatitis-c-virus-9876/</guid>
		<description><![CDATA[cobas(R) TaqScreen MPX Test is the most comprehensive - detects multiple viruses for increased plasma product safety

PLEASANTON, California, December 2  - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the United States
Food &#38; Drug Administration (FDA) approved an additional intended use for its
licensed nucleic acid test, to screen source plasma in pools comprised .... Original article on Gaea Times at  &nbsp;: <a href="http://pr.gaeatimes.com/fda-approves-use-of-roche-test-to-screen-source-plasma-for-hiv-hepatitis-b-virus-and-hepatitis-c-virus-9876/">FDA Approves Use of Roche Test to Screen Source Plasma for HIV, Hepatitis B Virus and Hepatitis C Virus</a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/fda-approves-use-of-roche-test-to-screen-source-plasma-for-hiv-hepatitis-b-virus-and-hepatitis-c-virus-9876/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Destination Therapy Trial Data Demonstrate Superiority for HeartMate II(R) Over HeartMate(R) XVE</title>
		<link>http://pr.gaeatimes.com/destination-therapy-trial-data-demonstrate-superiority-for-heartmate-iir-over-heartmater-xve-9106/</link>
		<comments>http://pr.gaeatimes.com/destination-therapy-trial-data-demonstrate-superiority-for-heartmate-iir-over-heartmater-xve-9106/#comments</comments>
		<pubDate>Tue, 17 Nov 2009 05:00:00 +0000</pubDate>
		<dc:creator>Thoratec Corporation</dc:creator>
		
		<category><![CDATA[Clinical Trials / Medical Discoveries]]></category>

		<category><![CDATA[Health]]></category>

		<category><![CDATA[Pharmaceuticals]]></category>

		<category><![CDATA[california]]></category>

		<category><![CDATA[France]]></category>

		<category><![CDATA[Germany]]></category>

		<category><![CDATA[Pacific]]></category>

		<category><![CDATA[Pleasanton]]></category>

		<category><![CDATA[Thoratec Corporation]]></category>

		<category><![CDATA[United Kingdom]]></category>

		<guid isPermaLink="false">http://blog.taragana.com/pr/destination-therapy-trial-data-demonstrate-superiority-for-heartmate-iir-over-heartmater-xve-9106/</guid>
		<description><![CDATA[STUDY SHOWS TWO-YEAR SURVIVAL OF 58 PERCENT AND DRAMATIC IMPROVEMENT IN QUALITY OF LIFE FOR HEARTMATE II PATIENTS

PLEASANTON, California, November 17  - Thoratec Corporation (Nasdaq: THOR), a world leader in device-based
mechanical circulatory support therapies to save, support and restore failing
hearts, said that data released today from the Destination Therapy (DT)
pivotal trial for the HeartMate ... <a href="http://pr.gaeatimes.com/destination-therapy-trial-data-demonstrate-superiority-for-heartmate-iir-over-heartmater-xve-9106/">Read the original article on Gaea Times at  : Destination Therapy Trial Data Demonstrate Superiority for HeartMate II(R) Over HeartMate(R) XVE</a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/destination-therapy-trial-data-demonstrate-superiority-for-heartmate-iir-over-heartmater-xve-9106/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Roche Introduces New cobas p 630 Instrument and AMPLILINK 3.3 Series Software With CE Mark</title>
		<link>http://pr.gaeatimes.com/roche-introduces-new-cobas-p-630-instrument-and-amplilink-33-series-software-with-ce-mark-8135/</link>
		<comments>http://pr.gaeatimes.com/roche-introduces-new-cobas-p-630-instrument-and-amplilink-33-series-software-with-ce-mark-8135/#comments</comments>
		<pubDate>Wed, 28 Oct 2009 05:00:00 +0000</pubDate>
		<dc:creator>Prne</dc:creator>
		
		<category><![CDATA[Business]]></category>

		<category><![CDATA[Computer / Electronics]]></category>

		<category><![CDATA[Health]]></category>

		<category><![CDATA[Health Care / Hospitals]]></category>

		<category><![CDATA[Infectious Disease Control]]></category>

		<category><![CDATA[Medical Equipment]]></category>

		<category><![CDATA[New Products / Services]]></category>

		<category><![CDATA[Pharmaceuticals]]></category>

		<category><![CDATA[Technology]]></category>

		<category><![CDATA[california]]></category>

		<category><![CDATA[Pleasanton]]></category>

		<category><![CDATA[Roche Molecular Diagnostics]]></category>

		<category><![CDATA[Russia]]></category>

		<category><![CDATA[Western Europe]]></category>

		<guid isPermaLink="false">http://blog.taragana.com/pr/roche-introduces-new-cobas-p-630-instrument-and-amplilink-33-series-software-with-ce-mark-8135/</guid>
		<description><![CDATA[PLEASANTON, California - 
- New pre-analytical solution that integrates automated primary tube handling

Roche Molecular Diagnostics (SIX: RO, ROG; OTCQX: RHHBY) announced today the availability of the cobas p 630 Instrument with CE Mark and the AMPLILINK 3.3 Series Software. The cobas p 630 Instrument and the AMPLILINK 3.3 Series Software is intended for the EU ... Read this article on Gaea Times at  : <a href="http://pr.gaeatimes.com/roche-introduces-new-cobas-p-630-instrument-and-amplilink-33-series-software-with-ce-mark-8135/">Roche Introduces New cobas p 630 Instrument and AMPLILINK 3.3 Series Software With CE Mark</a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/roche-introduces-new-cobas-p-630-instrument-and-amplilink-33-series-software-with-ce-mark-8135/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Trapeze Networks Announces World&#8217;s First Centrally-Managed Enterprise-Class 802.11n Outdoor AP</title>
		<link>http://pr.gaeatimes.com/trapeze-networks-announces-worlds-first-centrally-managed-enterprise-class-80211n-outdoor-ap-7271/</link>
		<comments>http://pr.gaeatimes.com/trapeze-networks-announces-worlds-first-centrally-managed-enterprise-class-80211n-outdoor-ap-7271/#comments</comments>
		<pubDate>Mon, 12 Oct 2009 05:00:00 +0000</pubDate>
		<dc:creator>Prne</dc:creator>
		
		<category><![CDATA[Business]]></category>

		<category><![CDATA[Computer / Electronics]]></category>

		<category><![CDATA[New Products / Services]]></category>

		<category><![CDATA[Technology]]></category>

		<category><![CDATA[Wireless Communications]]></category>

		<category><![CDATA[california]]></category>

		<category><![CDATA[Pleasanton]]></category>

		<category><![CDATA[Trapeze Networks]]></category>

		<category><![CDATA[United Kingdom]]></category>

		<guid isPermaLink="false">http://blog.taragana.com/pr/trapeze-networks-announces-worlds-first-centrally-managed-enterprise-class-80211n-outdoor-ap-7271/</guid>
		<description><![CDATA[PLEASANTON, California - 
- NonStop Wireless 802.11n Access Point Delivers Fast, Secure, Reliable Coverage Anywhere

Trapeze Networks, a Belden Brand (NYSE: BDC), today introduces the world&#8217;s first centrally-managed, enterprise-class outdoor 802.11n access point. The MP-632 is the newest member of Trapeze Networks&#8217; growing family of NonStop Wireless access points and can be easily configured to create .... Source article on Gaea Times at  &nbsp;: <a href="http://pr.gaeatimes.com/trapeze-networks-announces-worlds-first-centrally-managed-enterprise-class-80211n-outdoor-ap-7271/">Trapeze Networks Announces World&#8217;s First Centrally-Managed Enterprise-Class 802.11n Outdoor AP</a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/trapeze-networks-announces-worlds-first-centrally-managed-enterprise-class-80211n-outdoor-ap-7271/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Trapeze Networks Announces Trapeze Medical, Bringing Medical-Grade Mobility to Healthcare Market</title>
		<link>http://pr.gaeatimes.com/trapeze-networks-announces-trapeze-medical-bringing-medical-grade-mobility-to-healthcare-market-6898/</link>
		<comments>http://pr.gaeatimes.com/trapeze-networks-announces-trapeze-medical-bringing-medical-grade-mobility-to-healthcare-market-6898/#comments</comments>
		<pubDate>Mon, 05 Oct 2009 05:00:00 +0000</pubDate>
		<dc:creator>Prne</dc:creator>
		
		<category><![CDATA[Business]]></category>

		<category><![CDATA[Computer / Electronics]]></category>

		<category><![CDATA[Health]]></category>

		<category><![CDATA[Health Care / Hospitals]]></category>

		<category><![CDATA[New Products / Services]]></category>

		<category><![CDATA[Technology]]></category>

		<category><![CDATA[Wireless Communications]]></category>

		<category><![CDATA[california]]></category>

		<category><![CDATA[Pleasanton]]></category>

		<category><![CDATA[Trapeze Networks]]></category>

		<category><![CDATA[Western Europe]]></category>

		<guid isPermaLink="false">http://blog.taragana.com/pr/trapeze-networks-announces-trapeze-medical-bringing-medical-grade-mobility-to-healthcare-market-6898/</guid>
		<description><![CDATA[PLEASANTON, California - 
- Ambitious International Program Targets Solutions, Channel and Customers

Trapeze Networks, a Belden Brand (NYSE: BDC), today announced an ambitious program, &#8220;Trapeze Medical,&#8221; with the goal of extending the company&#8217;s leadership in the international Wireless LAN healthcare market. Trapeze Medical is focused on three strategies: It will increase the number of Medical-Grade Mobility(TM) .... Original article on Gaea Times at  &nbsp;: <a href="http://pr.gaeatimes.com/trapeze-networks-announces-trapeze-medical-bringing-medical-grade-mobility-to-healthcare-market-6898/">Trapeze Networks Announces Trapeze Medical, Bringing Medical-Grade Mobility to Healthcare Market</a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/trapeze-networks-announces-trapeze-medical-bringing-medical-grade-mobility-to-healthcare-market-6898/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Best Vienna Hotel Selects Best NonStop Wi-Fi Network</title>
		<link>http://pr.gaeatimes.com/best-vienna-hotel-selects-best-nonstop-wi-fi-network-5943/</link>
		<comments>http://pr.gaeatimes.com/best-vienna-hotel-selects-best-nonstop-wi-fi-network-5943/#comments</comments>
		<pubDate>Mon, 14 Sep 2009 05:00:00 +0000</pubDate>
		<dc:creator>Prne</dc:creator>
		
		<category><![CDATA[Computer / Electronics]]></category>

		<category><![CDATA[Leisure]]></category>

		<category><![CDATA[Technology]]></category>

		<category><![CDATA[Telecommunications]]></category>

		<category><![CDATA[Travel]]></category>

		<category><![CDATA[california]]></category>

		<category><![CDATA[Pleasanton]]></category>

		<category><![CDATA[Trapeze Networks]]></category>

		<category><![CDATA[United Kingdom]]></category>

		<guid isPermaLink="false">http://blog.taragana.com/pr/best-vienna-hotel-selects-best-nonstop-wi-fi-network-5943/</guid>
		<description><![CDATA[PLEASANTON, California - 
- Grand Hotel Wien Combines Majesty of Austro-Hungarian Empire With 21st Century NonStop Wireless Networking

Two hotels owned by the same company and located across the street from each other are delivering NonStop Wireless Networking from Trapeze Networks with only 210 access points - quite a feat for two buildings constructed in 1870 .... Source &nbsp;: <a href="http://pr.gaeatimes.com/best-vienna-hotel-selects-best-nonstop-wi-fi-network-5943/" title="Best Vienna Hotel Selects Best NonStop Wi-Fi Network">Gaea News Network</a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/best-vienna-hotel-selects-best-nonstop-wi-fi-network-5943/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Beijing Science Park Selects Trapeze Networks for Building Campus-Wide Wi-Fi Network</title>
		<link>http://pr.gaeatimes.com/beijing-science-park-selects-trapeze-networks-for-building-campus-wide-wi-fi-network-5636/</link>
		<comments>http://pr.gaeatimes.com/beijing-science-park-selects-trapeze-networks-for-building-campus-wide-wi-fi-network-5636/#comments</comments>
		<pubDate>Tue, 08 Sep 2009 05:00:00 +0000</pubDate>
		<dc:creator>Prne</dc:creator>
		
		<category><![CDATA[Business]]></category>

		<category><![CDATA[Computer / Electronics]]></category>

		<category><![CDATA[Licensing / Marketing Agreements]]></category>

		<category><![CDATA[Technology]]></category>

		<category><![CDATA[Wireless Communications]]></category>

		<category><![CDATA[california]]></category>

		<category><![CDATA[Pleasanton]]></category>

		<category><![CDATA[Trapeze Networks]]></category>

		<category><![CDATA[United Kingdom]]></category>

		<guid isPermaLink="false">http://blog.taragana.com/pr/beijing-science-park-selects-trapeze-networks-for-building-campus-wide-wi-fi-network-5636/</guid>
		<description><![CDATA[PLEASANTON, California - 
- China&#8217;s Leading High-Tech Business Incubator Depends on Trapeze Networks&#8217; NonStop Wireless

Trapeze Networks, a Belden Brand (NYSE: BDC), today announced that Hi-Tech International Business Incubator Co., Ltd. (HTIBI), the incubation center at the heart of Beijing&#8217;s Science Park, has deployed a campus-wide WLAN network based on Trapeze&#8217;s Smart Mobile(TM) architecture. The new ... <a href="http://pr.gaeatimes.com/beijing-science-park-selects-trapeze-networks-for-building-campus-wide-wi-fi-network-5636/">Read more : Beijing Science Park Selects Trapeze Networks for Building Campus-Wide Wi-Fi Network</a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/beijing-science-park-selects-trapeze-networks-for-building-campus-wide-wi-fi-network-5636/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Largest Interdisciplinary Research Center in Europe Implements Trapeze Networks&#8217; NonStop Wireless Networking</title>
		<link>http://pr.gaeatimes.com/largest-interdisciplinary-research-center-in-europe-implements-trapeze-networks-nonstop-wireless-networking-5320/</link>
		<comments>http://pr.gaeatimes.com/largest-interdisciplinary-research-center-in-europe-implements-trapeze-networks-nonstop-wireless-networking-5320/#comments</comments>
		<pubDate>Mon, 31 Aug 2009 05:00:00 +0000</pubDate>
		<dc:creator>Prne</dc:creator>
		
		<category><![CDATA[Contracts]]></category>

		<category><![CDATA[Investors]]></category>

		<category><![CDATA[Technology]]></category>

		<category><![CDATA[Telecommunications]]></category>

		<category><![CDATA[Wireless Communications]]></category>

		<category><![CDATA[california]]></category>

		<category><![CDATA[Pleasanton]]></category>

		<category><![CDATA[Trapeze Networks]]></category>

		<category><![CDATA[United Kingdom]]></category>

		<guid isPermaLink="false">http://blog.taragana.com/pr/largest-interdisciplinary-research-center-in-europe-implements-trapeze-networks-nonstop-wireless-networking-5320/</guid>
		<description><![CDATA[PLEASANTON, California - 
- Julich Research Center Researches Wide Range of Issues With Help of Trapeze Wireless Networking

With 4,400 employees, Julich is one of Europe&#8217;s largest research centers. Julich recently selected the Trapeze NonStop Wireless Networking as its WLAN platform for its optimal reliability and security because the center is responsible for the most important .... Original article on Gaea Times at  &nbsp;: <a href="http://pr.gaeatimes.com/largest-interdisciplinary-research-center-in-europe-implements-trapeze-networks-nonstop-wireless-networking-5320/">Largest Interdisciplinary Research Center in Europe Implements Trapeze Networks&#8217; NonStop Wireless Networking</a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/largest-interdisciplinary-research-center-in-europe-implements-trapeze-networks-nonstop-wireless-networking-5320/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Trapeze Networks: Working to Raise the Bar on Customer Satisfaction</title>
		<link>http://pr.gaeatimes.com/trapeze-networks-working-to-raise-the-bar-on-customer-satisfaction-4936/</link>
		<comments>http://pr.gaeatimes.com/trapeze-networks-working-to-raise-the-bar-on-customer-satisfaction-4936/#comments</comments>
		<pubDate>Mon, 17 Aug 2009 05:00:00 +0000</pubDate>
		<dc:creator>Prne</dc:creator>
		
		<category><![CDATA[Business]]></category>

		<category><![CDATA[Computer / Electronics]]></category>

		<category><![CDATA[Surveys / Polls / Research]]></category>

		<category><![CDATA[Technology]]></category>

		<category><![CDATA[california]]></category>

		<category><![CDATA[Pleasanton]]></category>

		<category><![CDATA[Trapeze Networks]]></category>

		<category><![CDATA[United Kingdom]]></category>

		<guid isPermaLink="false">http://blog.taragana.com/pr/trapeze-networks-working-to-raise-the-bar-on-customer-satisfaction-4936/</guid>
		<description><![CDATA[PLEASANTON, California - 
- Part of Overall Belden Quality Program
Trapeze Networks (NYSE: BDC) today announced it is now aligned with Belden&#8217;s overall quality initiative. As part of this initiative, customer feedback was collected via web based customer surveys to measure the customer service and support teams effectiveness and customer satisfaction rate.

Trapeze supports a diverse set ... <a href="http://pr.gaeatimes.com/trapeze-networks-working-to-raise-the-bar-on-customer-satisfaction-4936/">Read the original article on Gaea Times at  : Trapeze Networks: Working to Raise the Bar on Customer Satisfaction</a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/trapeze-networks-working-to-raise-the-bar-on-customer-satisfaction-4936/feed/</wfw:commentRss>
		</item>
		<item>
		<title>802.11n Finalization Feeding Frenzy Fascinating Folks From Fairbanks to Florida</title>
		<link>http://pr.gaeatimes.com/80211n-finalization-feeding-frenzy-fascinating-folks-from-fairbanks-to-florida-4548/</link>
		<comments>http://pr.gaeatimes.com/80211n-finalization-feeding-frenzy-fascinating-folks-from-fairbanks-to-florida-4548/#comments</comments>
		<pubDate>Thu, 30 Jul 2009 05:00:00 +0000</pubDate>
		<dc:creator>Prne</dc:creator>
		
		<category><![CDATA[Business]]></category>

		<category><![CDATA[Computer / Electronics]]></category>

		<category><![CDATA[New Products / Services]]></category>

		<category><![CDATA[Technology]]></category>

		<category><![CDATA[california]]></category>

		<category><![CDATA[Pleasanton]]></category>

		<category><![CDATA[Trapeze Networks]]></category>

		<category><![CDATA[United Kingdom]]></category>

		<guid isPermaLink="false">http://blog.taragana.com/pr/80211n-finalization-feeding-frenzy-fascinating-folks-from-fairbanks-to-florida-4548/</guid>
		<description><![CDATA[PLEASANTON, California - 
- LBAC Launch Learning Leap Too
Earlier this month, Matthew Gast, chief strategist in the office of the Chief Technology Officer of Trapeze Networks (www.trapezenetworks.com/) (NYSE: BDC), sparked a news feeding frenzy on his blog (blog.matthewgast.com/2009/07/20/80211n-is-almost-done/) when he wrote that the final vote to ratify 802.11n could take place as early as September ... <a href="http://pr.gaeatimes.com/80211n-finalization-feeding-frenzy-fascinating-folks-from-fairbanks-to-florida-4548/">Read : 802.11n Finalization Feeding Frenzy Fascinating Folks From Fairbanks to Florida</a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/80211n-finalization-feeding-frenzy-fascinating-folks-from-fairbanks-to-florida-4548/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Trapeze Networks and TESSCO Technologies Announce Distribution Alliance</title>
		<link>http://pr.gaeatimes.com/trapeze-networks-and-tessco-technologies-announce-distribution-alliance-4433/</link>
		<comments>http://pr.gaeatimes.com/trapeze-networks-and-tessco-technologies-announce-distribution-alliance-4433/#comments</comments>
		<pubDate>Mon, 27 Jul 2009 05:00:00 +0000</pubDate>
		<dc:creator>Prne</dc:creator>
		
		<category><![CDATA[Business]]></category>

		<category><![CDATA[Computer / Electronics]]></category>

		<category><![CDATA[Licensing / Marketing Agreements]]></category>

		<category><![CDATA[Technology]]></category>

		<category><![CDATA[california]]></category>

		<category><![CDATA[Pleasanton]]></category>

		<category><![CDATA[Trapeze Networks]]></category>

		<category><![CDATA[United Kingdom]]></category>

		<guid isPermaLink="false">http://blog.taragana.com/pr/trapeze-networks-and-tessco-technologies-announce-distribution-alliance-4433/</guid>
		<description><![CDATA[PLEASANTON, California - 
- New Agreement to Expand Trapeze Networks&#8217; Reach to More Than 100 Countries

Trapeze Networks (NYSE: BDC), a leader in enterprise wireless LAN equipment and management software, and TESSCO Technologies Incorporated (www.tessco.com/) (Nasdaq: TESS), a value-added provider of the product and supply chain solutions needed to design, build, run, maintain and use wireless .... <a href="http://pr.gaeatimes.com/trapeze-networks-and-tessco-technologies-announce-distribution-alliance-4433/">Read the original article &nbsp;: Trapeze Networks and TESSCO Technologies Announce Distribution Alliance</a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/trapeze-networks-and-tessco-technologies-announce-distribution-alliance-4433/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Trapeze Networks&#8217; Matthew Gast Reports 802.11n Approaching Final Approval</title>
		<link>http://pr.gaeatimes.com/trapeze-networks-matthew-gast-reports-80211n-approaching-final-approval-4308/</link>
		<comments>http://pr.gaeatimes.com/trapeze-networks-matthew-gast-reports-80211n-approaching-final-approval-4308/#comments</comments>
		<pubDate>Tue, 21 Jul 2009 05:00:00 +0000</pubDate>
		<dc:creator>Prne</dc:creator>
		
		<category><![CDATA[Computer / Electronics]]></category>

		<category><![CDATA[Technology]]></category>

		<category><![CDATA[california]]></category>

		<category><![CDATA[Pleasanton]]></category>

		<category><![CDATA[Trapeze Networks]]></category>

		<category><![CDATA[United Kingdom]]></category>

		<guid isPermaLink="false">http://blog.taragana.com/pr/trapeze-networks-matthew-gast-reports-80211n-approaching-final-approval-4308/</guid>
		<description><![CDATA[PLEASANTON, California - 
- Vote Takes Place This Fall
Matthew Gast, chief strategist in the office of the Chief Technology Officer, has announced on his blog (blog.matthewgast.com/2009/07/20/80211n-is-almost-done/ ) that the final vote to ratify 802.11n could take place as early as September 11, 2009. It has taken exactly seven years to specify and approve 802.11n. Already, ... Read more : <a href="http://pr.gaeatimes.com/trapeze-networks-matthew-gast-reports-80211n-approaching-final-approval-4308/">Trapeze Networks&#8217; Matthew Gast Reports 802.11n Approaching Final Approval</a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/trapeze-networks-matthew-gast-reports-80211n-approaching-final-approval-4308/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Trapeze Networks Awarded Two More Breakthrough Patents</title>
		<link>http://pr.gaeatimes.com/trapeze-networks-awarded-two-more-breakthrough-patents-4248/</link>
		<comments>http://pr.gaeatimes.com/trapeze-networks-awarded-two-more-breakthrough-patents-4248/#comments</comments>
		<pubDate>Mon, 20 Jul 2009 05:00:00 +0000</pubDate>
		<dc:creator>Prne</dc:creator>
		
		<category><![CDATA[Computer / Electronics]]></category>

		<category><![CDATA[Government and Policy]]></category>

		<category><![CDATA[High Tech Security]]></category>

		<category><![CDATA[Patent Law]]></category>

		<category><![CDATA[Technology]]></category>

		<category><![CDATA[california]]></category>

		<category><![CDATA[Fact]]></category>

		<category><![CDATA[Pleasanton]]></category>

		<category><![CDATA[Trapeze Networks]]></category>

		<category><![CDATA[United Kingdom]]></category>

		<guid isPermaLink="false">http://blog.taragana.com/pr/trapeze-networks-awarded-two-more-breakthrough-patents-4248/</guid>
		<description><![CDATA[PLEASANTON, California - 
- New Intellectual Property Covers New Location Based Access Control, Identity-Based Networking

The United States Patent Office has awarded Trapeze Networks (NYSE: BDC) two more breakthrough wireless networking patents. The patents advance the company&#8217;s position in wireless network security and role-based access control.
&#8220;Awarded patents are important because they protect our intellectual property and .... Source &nbsp;: <a href="http://pr.gaeatimes.com/trapeze-networks-awarded-two-more-breakthrough-patents-4248/" title="Trapeze Networks Awarded Two More Breakthrough Patents">Gaea News Network</a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/trapeze-networks-awarded-two-more-breakthrough-patents-4248/feed/</wfw:commentRss>
		</item>
	</channel>
</rss>

